Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine

Chronic migraine (CM) prevalence ranges around 1–5%. Most of these patients usually treat their acute attacks with triptans, whose efficacy is extremely variable. A genetic basis for migraine is evident and many susceptibility genes have been described, as well as gene polymorphisms possibly implied...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Giovanna, Missori, Serena, Borro, Marina, Sebastianelli, Alisa, Simmaco, Maurizio, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2010
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452288/
https://www.ncbi.nlm.nih.gov/pubmed/20213484
http://dx.doi.org/10.1007/s10194-010-0202-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452288/
https://www.ncbi.nlm.nih.gov/pubmed/20213484
http://dx.doi.org/10.1007/s10194-010-0202-7

Ejemplares similares